Lexington, Mass.-based T2 Biosystems Inc. won breakthrough device designation for the T2resistance panel, which can detect 13 resistance genes from both gram-positive and gram-negative pathogens. Of note, it can detect those pathogens from a single patient blood sample, without the wait for a blood culture.
Read More
